Previous Article | Next Article ![]()
Molecular and Cellular Biology, May 2000, p. 3168-3177, Vol. 20, No. 9
Department of Physiology, University of
Michigan Medical School, Ann Arbor, Michigan 48109-0622
Received 7 July 1999/Returned for modification 10 October
1999/Accepted 31 January 2000
SH2-B
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Differential Binding to and Regulation of JAK2 by
the SH2 Domain and N-Terminal Region of SH2-B
has been shown to bind via its SH2 (Src homology 2) domain
to tyrosyl-phosphorylated JAK2 and strongly activate JAK2. In this
study, we demonstrate the existence of an additional binding site(s)
for JAK2 within the N-terminal region of SH2-B
(amino acids 1 to
555) and the ability of this region of SH2-B to inhibit JAK2. Four
lines of evidence support the existence of this additional binding
site(s). In a glutathione S-transferase pull-down assay, wild-type SH2-B
and SH2-B
(R555E) with a defective SH2 domain bind
to both tyrosyl-phosphorylated JAK2 from growth hormone (GH)-treated cells and non-tyrosyl-phosphorylated JAK2 from control cells, whereas
the SH2 domain of SH2-B
binds only to tyrosyl-phosphorylated JAK2
from GH-treated cells. Similarly, JAK2 is present in
SH2-B immunoprecipitates in the absence and presence of GH, with GH substantially increasing the coprecipitation of JAK2 with SH2-B. When
coexpressed in COS cells, SH2-B
coimmunoprecipitates not only
wild-type, tyrosyl-phosphorylated JAK2 but also kinase-inactive, non-tyrosyl-phosphorylated JAK2(K882E), although to a lesser extent.
C555 (amino acids 1 to 555 of SH2-B
) that lacks most of the SH2
domain binds similarly to wild-type JAK2 and kinase-inactive JAK2(K882E). Experiments using a series of N- and C-terminally truncated SH2-B
constructs indicate that the pleckstrin homology (PH) domain (amino acids 269 to 410) and amino acids 410 to 555 are
necessary for maximal binding of SH2-B
to inactive JAK2, but neither
region alone is sufficient for maximal binding. The SH2 domain of
SH2-B
is necessary and sufficient for the stimulatory effect of
SH2-B
on JAK2 and JAK2-mediated tyrosyl phosphorylation of Stat5B.
In contrast,
C555 lacking the SH2 domain, and to a lesser extent the
PH domain alone, inhibits JAK2.
C555 also blocks JAK2-mediated
tyrosyl phosphorylation of Stat5B in COS cells and GH-stimulated
nuclear accumulation of Stat5B in 3T3-F442A cells. These data indicate
that in addition to the SH2 domain, SH2-B
has one or more
lower-affinity binding sites for JAK2 within amino acids 269 to 555. The interaction via this site(s) in SH2-B with inactive JAK2 seems
likely to increase the local concentration of SH2-B
around JAK2,
thereby facilitating binding of the SH2 domain to ligand-activated
JAK2. This would result in a more rapid and robust cellular response to
hormones and cytokines that activate JAK2. This interaction between
inactive JAK2 and SH2-B may also help prevent abnormal activation of JAK2.
*
Corresponding author. Mailing address: Department of
Physiology, The University of Michigan Medical School, Ann Arbor, MI 48109-0622. Phone: (734) 763-2561. Fax: (734) 647-9523. E-mail: cartersu{at}umich.edu.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|